Soligenix Stock Performance
| SNGX Stock | USD 1.42 0.08 5.97% |
On a scale of 0 to 100, Soligenix holds a performance score of 3. The entity has a beta of 0.87, which indicates possible diversification benefits within a given portfolio. Soligenix returns are very sensitive to returns on the market. As the market goes up or down, Soligenix is expected to follow. Please check Soligenix's value at risk, as well as the relationship between the kurtosis and price action indicator , to make a quick decision on whether Soligenix's existing price patterns will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Soligenix are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady technical and fundamental indicators, Soligenix showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:16 | Dividend Date 2016-10-07 | Last Split Date 2024-06-06 |
1 | Acquisition by Lapointe Anthony Gregg of 8646 shares of Soligenix at 3.47 subject to Rule 16b-3 | 10/08/2025 |
2 | Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks Featuring Gladerma, Sun Pharmaceutical, Biofrontera, Lumibird, Baus... | 10/31/2025 |
3 | How geopolitical tensions affect Soligenix Inc. stock - July 2025 Big Picture Technical Pattern Recognition Alerts - newser.com | 11/14/2025 |
4 | Will Soligenix Inc. stock gain from lower interest rates - Market Sentiment Review Free Safe Entry Trade Signal Reports - newser.com | 11/18/2025 |
5 | Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte for the Treatment of Cutaneous T-Cell Lym... | 11/19/2025 |
6 | Acquisition by Parks Diane L. of 17647 shares of Soligenix at 1.7 subject to Rule 16b-3 | 11/21/2025 |
7 | Soligenix Inc. Innovative Platform Provides Novel Treatment for Underserved CTCL Space | 12/03/2025 |
8 | Soligenix Inc. Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad | 12/05/2025 |
9 | Soligenix Receives Strong Vote of Confidence from Zacks Report Despite Muted Market Response to Clinical Milestone - Digital Journal | 12/09/2025 |
10 | Acquisition by Christopher Schaber of 200000 shares of Soligenix at 1.63 subject to Rule 16b-3 | 12/11/2025 |
11 | Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 in Patients with Mild-to-Moderate Psoriasis | 12/17/2025 |
12 | SNGX Positive Results for Phase 2a Trial in Psoriasis | 12/22/2025 |
Soligenix | Build AI portfolio with Soligenix Stock |
Soligenix Relative Risk vs. Return Landscape
If you would invest 137.00 in Soligenix on October 5, 2025 and sell it today you would earn a total of 5.00 from holding Soligenix or generate 3.65% return on investment over 90 days. Soligenix is currently generating 0.214% in daily expected returns and assumes 5.6474% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than Soligenix, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Soligenix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Soligenix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Soligenix, and traders can use it to determine the average amount a Soligenix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0379
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SNGX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Soligenix is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Soligenix by adding it to a well-diversified portfolio.
Soligenix Fundamentals Growth
Soligenix Stock prices reflect investors' perceptions of the future prospects and financial health of Soligenix, and Soligenix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Soligenix Stock performance.
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.69 | ||||
| Current Valuation | 3.38 M | ||||
| Shares Outstanding | 10.09 M | ||||
| Price To Earning | (1.67) X | ||||
| Price To Book | 1.78 X | ||||
| Price To Sales | 3,875 X | ||||
| Revenue | 119.37 K | ||||
| EBITDA | (9.46 M) | ||||
| Net Income | (8.27 M) | ||||
| Cash And Equivalents | 20.16 M | ||||
| Cash Per Share | 0.47 X | ||||
| Total Debt | 1.48 M | ||||
| Debt To Equity | 2.44 % | ||||
| Current Ratio | 2.36 X | ||||
| Book Value Per Share | 0.77 X | ||||
| Cash Flow From Operations | (8.4 M) | ||||
| Earnings Per Share | (3.44) X | ||||
| Market Capitalization | 13.52 M | ||||
| Total Asset | 8.97 M | ||||
| Retained Earnings | (233.97 M) | ||||
| Working Capital | 3.98 M | ||||
| Current Asset | 7.15 M | ||||
| Current Liabilities | 7.41 M | ||||
About Soligenix Performance
Evaluating Soligenix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Soligenix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Soligenix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 12.12 | 14.54 | |
| Return On Tangible Assets | (0.83) | (0.87) | |
| Return On Capital Employed | (2.06) | (1.96) | |
| Return On Assets | (0.83) | (0.87) | |
| Return On Equity | (1.81) | (1.72) |
Things to note about Soligenix performance evaluation
Checking the ongoing alerts about Soligenix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Soligenix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Soligenix had very high historical volatility over the last 90 days | |
| Soligenix may become a speculative penny stock | |
| Soligenix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 119.37 K. Net Loss for the year was (8.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Soligenix currently holds about 20.16 M in cash with (8.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47. | |
| Soligenix has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: SNGX Positive Results for Phase 2a Trial in Psoriasis |
- Analyzing Soligenix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Soligenix's stock is overvalued or undervalued compared to its peers.
- Examining Soligenix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Soligenix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Soligenix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Soligenix's stock. These opinions can provide insight into Soligenix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Soligenix Stock Analysis
When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.